Company & Sponsor Intelligence
The Cleveland Clinic
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting1
Completed3
Countries1
Therapeutic footprint
alzheimersepilepsyparkinsons
Indexed studies
NCT07442747Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS
parkinsons · United StatesPHASE2
parkinsons · United StatesPHASE2
NCT04000360Pragmatic Cyclical Lower Extremity Exercise Trial for Parkinson's Disease
parkinsons · United StatesNA
parkinsons · United StatesNA
NCT00361010A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy
epilepsy · United StatesNA
epilepsy · United StatesNA
NCT03923920Screening for Systemic Amyloidosis Via the Ligamentum Flavum
alzheimers · United StatesCOMPLETED
alzheimers · United StatesCOMPLETED
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →